EC
PRQR icon

EcoR1 Capital’s ProQR Therapeutics PRQR Stock Holding History

EcoR1 Capital’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,835,991
Closed -$3.34M – 71
2024
Q3 		$3.34M Sell
1,835,991
-206,780
-10% -$388K 0.11% 52
2024
Q2 		$3.39M Sell
2,042,771
-841,586
-29% -$1.63M 0.1% 49
2024
Q1 		$6.6M Sell
2,884,357
-95,659
-3% -$205K 0.17% 49
2023
Q4 		$5.9M Hold
2,980,016
– – 0.15% 37
2023
Q3 		$3.87M Hold
2,980,016
– – 0.13% 40
2023
Q2 		$4.83M Buy
2,980,016
+77,301
+3% +$151K 0.12% 41
2023
Q1 		$6.18M Buy
+2,902,715
New +$8.87M 0.2% 37
2019
Q1 		– Sell
-11,022
Closed -$174K – 51
2018
Q4 		$174K Buy
+11,022
New +$202K 0.02% 53

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

EcoR1 Capital's PRQR Position: Q4 2024 in Review

EcoR1 Capital sold out of ProQR Therapeutics (PRQR) in Q4 2024, closing a stake of 1,835,991 shares — an estimated $3.34M sold.

EcoR1 Capital first reported a position in PRQR in Q4 2018 and held it in 8 quarters. The position peaked at $6.6M in Q1 2024. 77 funds tracked by Wall St. Rank hold PRQR as of Q4 2024.

  • EcoR1 Capital reported no remaining ProQR Therapeutics position as of Q4 2024 after selling out during the quarter.
  • EcoR1 Capital sold 1,835,991 ProQR Therapeutics shares in Q4 2024, an estimated $3.34M.
  • EcoR1 Capital first reported a position in ProQR Therapeutics in Q4 2018 and held it in 8 quarters.
  • EcoR1 Capital's ProQR Therapeutics position peaked at $6.6M in Q1 2024.
  • 77 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q4 2024.

Based on EcoR1 Capital's 13F filing for Q4 2024, filed 14 Feb 2025.